CoChat

Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study

Open access
Petkova, Eva, Ogden, R. Todd, Tarpey, Thaddeus, Ciarleglio, Adam, Jiang, Bei, Su, Zhe, Carmody, Thomas, Adams, Philip, Kraemer, Helena C., Grannemann, Bruce D., Oquendo, Maria A., Parsey, Ramin, Weissman, Myrna, McGrath, Patrick J., Fava, Maurizio, Trivedi, Madhukar H. · 2017 · Contemporary Clinical Trials Communications
Cited by 23

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Antidepressant medications are commonly used to treat depression, but only about 30% of patients reach remission with any single first-step antidepressant. If the first-step treatment fails, response and remission rates at subsequent steps are even more limited. The literature on biomarkers for treatment response is largely based on secondary analyses of studies designed to answer primary questions of efficacy, rather than on a planned systematic evaluation of biomarkers for treatment decision. The lack of evidence-based knowledge to guide treatment decisions for patients with depression has lead to the recognition that specially designed studies with the primary objective being to discover biosignatures for optimizing treatment decisions are necessary. Establishing Moderators and Biosignatures of Antidepressant Response in Clinical Care (EMBARC) is one such discovery study. Stage 1 of EMBARC is a randomized placebo controlled clinical trial of 8 week duration. A wide array of patient characteristics is collected at baseline, including assessments of brain structure, function and connectivity along with electrophysiological, biological, behavioral and clinical features. This paper reports on the data analytic strategy for discovering biosignatures for treatment response based on Stage 1 of EMBARC.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.conctc.2017.02.007

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 23

Metadata

Authors
Petkova, E., Ogden, R. T., Tarpey, T., Ciarleglio, A., Jiang, B., Su, Z., Carmody, T., Adams, P., Kraemer, H. C., Grannemann, B. D., Oquendo, M. A., Parsey, R., Weissman, M., McGrath, P. J., Fava, M., & Trivedi, M. H.
Venue
Contemporary Clinical Trials Communications
Publisher
Elsevier BV
Published
2017-06
Volume
6
Pages
22-30
ISSN
2451-8654 (ISSN-L)
OpenAlex
W2590143221
Cited by
23
References
5
FWCI
2.45
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study. https://app.cochat.ai/papers/10.1016/j.conctc.2017.02.007
The paper
Petkova, E., Ogden, R. T., Tarpey, T., Ciarleglio, A., Jiang, B., Su, Z., Carmody, T., Adams, P., Kraemer, H. C., Grannemann, B. D., Oquendo, M. A., Parsey, R., Weissman, M., McGrath, P. J., Fava, M., & Trivedi, M. H. (2017). Statistical analysis plan for stage 1 EMBARC (Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care) study. Contemporary Clinical Trials Communications. https://doi.org/10.1016/j.conctc.2017.02.007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.